Graeme Ian Murray
Use of CYP1B1 inhibitors for treating cancer.
Murray, Graeme Ian; Melvin, William Thomas; McFadyen, Morag
William Thomas Melvin
CYP1B1 proteins and their role in metabolising or inactivating anti-cancer drugs are disclosed, together with compositions for treating cancer comprising a substance capable of inhibiting CYP1B1 protein and an anti-cancer drug (e.g. docetaxel, paclitaxel, flutamide, tamoxifen, mitoxantrone, doxorubicin or daunomycin).
MURRAY, G.I., MELVIN, W.T. and MCFADYEN, M. 2001. Use of CYP1B1 inhibitors for treating cancer. International patent application PCT/GB2001/000548. International publication number WO/2001/058444 (WO 01/58444 A1), published 16.08.2001. Available from: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2001058444
|Publication Date||Aug 16, 2001|
|Deposit Date||Sep 8, 2020|
|Publicly Available Date||Sep 8, 2020|
|Keywords||Cytochrome P450; CYP1B1; Cancer treatments|
|Additional Information||Publication number WO/2001/058444 (WO 01/58444 A1). Also published as Australian Patent Office AU2001232060; Canadian Patent Office CA2399402; European Patent Office EP1261332; Japanese Patent Office JP2003522143; US Patent and Trademarks Office US20030162727.|
MURRAY 2001 Use of CYP1B1 inhibitors for treating cancer
Publisher Licence URL